2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide
| 中文名称 | 2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide |
|---|---|
| 中文同义词 | |
| 英文名称 | 2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide |
| 英文同义词 | 2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide;1H-Indole-3-acetamide, 1-(2,2-diethoxyethyl)-2,3-dihydro-N-(4-methylphenyl)-3-[[[(4-methylphenyl)amino]carbonyl]amino]-2-oxo-, (+)- |
| CAS号 | 159883-95-1 |
| 分子式 | C31H36N4O5 |
| 分子量 | 544.64 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 159883-95-1.mol |
| 结构式 | ![2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide 结构式](CAS/20180529/GIF/159883-95-1.gif) |
2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide 性质
| 熔点 | 100-102 °C |
|---|---|
| 沸点 | 766.6±60.0 °C(Predicted) |
| 密度 | 1.25±0.1 g/cm3(Predicted) |
| 储存条件 | Store at -20°C |
| 溶解度 | DMSO 中≤5mg/ml；二甲基甲酰胺中10mg/ml |
| 形态 | 结晶固体 |
| 酸度系数(pKa) | 10.31±0.20(Predicted) |
2-[(3R)-1-(2,2-diethoxyethyl)-3-[(4-methylphenyl)carbamoylamino]-2-oxoindol-3-yl]-N-(4-methylphenyl)acetamide 用途与合成方法
AG-041R 是一种有效的选择性的 CCK2 受体/胃泌素 (CCK2 Receptor/Gastrin) 拮抗剂。AG-041R 抑制胃泌素诱导的胰抑素分泌，其 IC50 为 2.2 nM。AG-041R 抑制 Mastomys ECL 类癌细胞的生长。